Transtem Patient 2014 solution is designed for blood and marrow transplant programs
LENEXA, KS, February 26, 2014 – Mediware Information Systems, Inc., a provider of comprehensive healthcare IT software solutions, announced the launch of the new Transtem Patient 2014 software for Blood and Marrow Transplant programs. The solution is designed to streamline transplant center operations while maintaining focus on quality. This single, specialized software solution allows transplant staff to efficiently manage patient, donor and product information all in one place, with the highest level of safety and security.
The Transtem Patient 2014 system has been designed to enhance the end-user experience through expanded data capture, automated registry reporting, a more robust informatics platform and integration of Mediware’s Maestro interface engine. This results in more automation, less duplicate data entry and reduced chance of error. Notable features include system populated registry reporting forms, one click CIBMTR form submission via AGNIS and deeper integration with hospital systems. Further, Transtem Patient 2014 provides powerful reporting and analysis capabilities utilizing patient, donor and product information like never before.
Mediware listened to the industry professionals and acted quickly. “Our team has worked hard to bring our clients the resources they are looking for to automate processes, increase data integrity and enhance compliance efforts while focusing on patient safety.” said Jonathan Wofford, Cellular Therapy Solutions General Manager.
Transtem Patient 2014 leverages automation and reporting in a whole new way, helping to meet the varying needs of this evolving industry. The solution is built to fit organizational needs now, as well as in the future. It was designed by cellular therapy professionals that work closely with industry agencies to ensure reporting requirements are easily and accurately met. In addition to facilitating communication between caregivers, the software also serves as a bridge to unite laboratory and clinical teams within a single environment.
“Mediware is proud to start the year with this latest innovation in our cellular therapy portfolio and we are committed to be responsive to the ever changing needs of this market and science,” noted Wofford.
Additional information about the full range of software capabilities is available online or by emailing firstname.lastname@example.org. Mediware will be exhibiting at the upcoming BMT Tandem 2014 meeting, February 26-March 2, in Grapevine, TX. Register to meet us at booth #103. Mediware will be hosting an exclusive Webinar for Transtem Patient, Wednesday, March 19th, at 11:00 a.m. CST. Register.
Mediware delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; cell therapy solutions for cord blood banks, transplant programs and cell therapy labs. For more information about Mediware products and services, visit our website at www.mediware.com.
About the Transtem Solution
Transtem was designed by cellular therapy professionals to provide a comprehensive solution for cell therapy labs, cord blood banks, BMT, transplant centers and academic medical centers to collect, process, transfuse and track adult and cord blood stem cells used in the treatment of cancer and blood related diseases. Transtem’s unique capabilities combine a focus on donors, products and patients to provide a 360-degree view of treatments and outcomes. In addition to the system’s comprehensive capabilities, Transtem is designed to improve productivity across the organization by integrating with other core information systems, such as an EMR (electronic medical record), for further productivity and safety benefits.